InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Discover the complete record of transactions filed by Martin Daniel C., Directeur Commercial. Insider active across 1 companies, notably Deciphera Pharmaceuticals, Inc.. In total, 7 filings have been published. Total volume traded: €32k. The latest transaction was filed on 16 June 2022 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations7 total
€13,3631,311 shares@ €10.192642.3% of flow
Common Stock
SEC:0001209191-22-038428:0·
€9,1321,146 shares@ €7.9688100.0% of flow
Common Stock
SEC:0001209191-22-011359·
€9,1321,146 shares@ €7.968828.9% of flow
Common Stock
SEC:0001209191-22-011359:0·
013,667 shares0
Common Stock
SEC:0001209191-22-004077:0·
013,667 shares0
Common Stock
SEC:0001209191-22-004077·
08,300 shares0
Common Stock
SEC:0001209191-21-070226·
08,300 shares0
Common Stock
SEC:0001209191-21-070226:0·
7 of 7 declarations
About Martin Daniel C.
Daniel C. Martin is the Chief Commercial Officer at Deciphera Pharmaceuticals, Inc., a biopharmaceutical company. He is responsible for commercial strategy and business development. His expertise in the pharmaceutical sector allows him to lead initiatives aimed at increasing the reach and impact of the company's products in the market.
